DOI: 10.3886/icpsr34988.v1
title: Criminal Justice Drug Abuse Treatment Studies 2: Medication-Assisted Therapy, 2010-2013 [United States]
title: Version 1

description: The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration.
The Medication-Assisted Therapy (MAT) study focuses on implementing linkages to medication assisted treatment in correctional settings. During the study period community corrections staff engaged in training about addiction pharmacotherapies, while leadership in the corrections and treatment facilities engage in a joint strategic planning process to identify and resolve barriers to efficient flow of clients across the two systems. 
 This study includes 28 datasets and over 1,400 variables. The first five datasets for this study contain data on the baseline characteristics of the treatment and corrections sites that participated in the study as well as the characteristics of the staff working at those facilities. Opinions about Medication Assisted Treatment surveys were administered to personnel at the participating corrections and treatment sites (D6). Data on Inter-organization Relations between Probation and Parole staff with Treatment Providers were also collected (DS7-DS18).
Information was extracted from the charts of clients about their alcohol and opioid dependence as well as the referrals and treatment the clients received (DS19). Probation and parole officers and treatment providers were surveyed about monthly counts of referrals (DS20-DS21).
During the study 10 staff members from the community corrections agency and local treatment providers where MAT services were available were nominated to participate in a Pharmacotherapy Exchange Council (PEC). PEC members were involved with strategic planning for implementing changes to improve the usage of Medication-Assisted Therapy. PEC members were surveyed several times throughout the study.
PEC members completed surveys on how well the sites were adhering to the Organizational Linkages Intervention (OLI) process (DS22). Community corrections staff, PEC members and Connections Coordinators in the experimental group were surveyed about their perceptions of organizational benefits and costs associated with the MATICCE intervention (DS23). The PEC rated the Connections Coordinators (DS24)and the Connections Coordinators rate the PEC (DS25). PEC researchers completed surveys on how much of the OLI was completed (DS26) as well as what the sustainability of the changes made through the MATTICE project (DS27). The final dataset provides a key for who took the KPI (Key Performance Indicators) training and who was a PEC member (DS28).
description: The objective of this study was to leverage treatment services that already exist in the community. This means that the implementation strategy was not designed to promote the delivery of clinical services nor medication prescribing within or by probation and parole offices, but rather was targeted at facilitating linkages between organizations that, despite sharing the same clients, lack incentive to coordinate services, or otherwise do not view themselves as sharing a common mission.
description: Nine research centers partnered with stakeholder organizations to improve utilization of medical-assisted therapy. Each research center recruited two community corrections agencies that did not have overlapping administrative structures. The pairs of sites were used in a clustered randomized design experiment. One research center recruited a second pair of sites brining the total number of sites to 20.
The sites' staff received a 3-hour medical assisted therapy. Next the experimental group of sites were assigned to received an Organization Linkage Intervention and were asked to nominate members of a "Pharmacotherapy Exchange Council" (PEC). The PEC went through a manualized strategic planning process with the end goal of facilitating inter-organization linkages and increase awareness about the effectiveness of Medication-assisted therapy.
description: There are no weights associated with this study.
description: Response Rates: Part 1: CD 91.3 percent / CO 91.2 percent / TD 95.8 percent / TS 84.5 percent
Part 2: 80.0 percent
Part 3: 85.7 percent
Part 4: Same as part 1
Part 5: N/A
Part 6: Baseline 85.2 percent / 3 Month 80.5 percent / 12 Month 74.5 percent
Part 7: 86.1 percent
Part 8: 72.9 percent
Part 9: 80.4 percent
Part 10: 82.2 percent
Part 11: 90.8 percent
Part 12: 93.3 percent
Part 13: 70.6 percent
Part 14: 95.0 percent
Part 15: 96.3 percent
Part 16: 90.6 percent
Part 17: 78.3 percent
Part 18: 92.3 percent
Part 19: N/A
Part 20: 98.2 percent
Part 21: 93.6 percent
Part 22: 100 percent
Part 23: 98.2 percent
Part 24: 93.3 percent
Part 25: 99.3 percent
Part 26: 100 percent
Part 27: 100 percent
Part 28: N/A
description: Presence of Common Scales: Please review the scoring guides in the provided user guide.
description: All applicable personnel at each study site were invited to participate.
description: Datasets: 
DS0: Study-Level Files
DS1: Baseline Survey of Organizational Characteristics - Merged TS, TD, CS, CD
DS2: Baseline Survey of Organizational Characteristics - Executive Corrections
DS3: Baseline Survey of Organizational Characteristics - Executive Treatment
DS4: Baseline Survey of Organizational Characteristics - Merged Demographics TS, TD, CS, CD
DS5: Tear Off Cover Sheet - Demographics
DS6: Opinions About Medication Assisted Treatment
DS7: Interorganizational Relationships (IOR): Probation/Parole Rating of Treatment Provider - Baseline
DS8: Interorganizational Relationships (IOR): Probation/Parole Rating of Treatment Provider - 12 Month
DS9: Interorganizational Relationships (IOR): Treatment Provider Rating of Probation/Parole - Baseline
DS10: Interorganizational Relationships (IOR): Treatment Provider Rating of Probation/Parole - 12 Month
DS11: Interorganizational Relationships (IOR): Probation/Parole Rating of TASC - Baseline
DS12: Interorganizational Relationships (IOR): Probation/Parole Rating of TASC - 12 Month
DS13: Interorganizational Relationships (IOR): TASC Rating of Probation/Parole - Baseline
DS14: Interorganizational Relationships (IOR): TASC Rating of Probation/Parole - 12 Month
DS15: Interorganizational Relationships (IOR): Treatment Provider Rating of TASC - Baseline
DS16: Interorganizational Relationships (IOR): Treatment Provider Rating of TASC - 12 Month
DS17: Interorganizational Relationships (IOR): TASC Rating of Treatment Provider - Baseline
DS18: Interorganizational Relationships (IOR): TASC Treatment Provider Rating of TASC - 12 Month
DS19: Agency Records Data Extraction Form
DS20: Monthly Count of Referrals: Probation/Parole Survey
DS21: Monthly Count of Referrals: Treatment Provider Survey
DS22: Medication Assisted Treatment in Community Correctional Environments (MATICCE) - Fidelity Measure
DS23: Satisfaction with the MATICCE Intervention
DS24: Working Alliance Between Connections Coordinator and Pharmacotherapy Exchange Council A: Ratings by the Members of the Pharmacotherapy Exchange Council
DS25: "Working Alliance Between Connections Coordinator and Pharmacotherapy Exchange Council
B: Ratings by the Connections Coordinator"
DS26: MATTICE Protocol - RC Involvement Checklist
DS27: MATTICE Sustainability Measures
DS28: KPI Training Completion and PEC Membership
description: Probation, parole, and treatment personnel in the United States 2010-2013.
description: record abstracts; on-site questionnaireICPSR edited variable labels to provide users with more information and increase comparability across variables sets and datasets.ICPSR performed recodes on select variables to protect respondent confidentiality. See the "Processing/Confidentiality Notes" in each codebook for further details.